Status:
UNKNOWN
Safety and Efficacy of Esmketamine Versus Dexmedetomidine
Lead Sponsor:
Zhongnan Hospital
Conditions:
Osa Syndrome
Eligibility:
All Genders
3-12 years
Phase:
PHASE4
Brief Summary
A comparative study on the safety and efficacy of esmketamine versus Dexmedetomidine during drug induced sleep endoscopy in children with positional obstructive sleep apnea: A consort-prospective, ran...
Detailed Description
Methods: Eighty ASA Ⅰ - Ⅱ patients aged 3-13 years underwent elective surgery under general anesthesia. No serious cardiovascular disease, no liver and kidney dysfunction, no central nervous system di...
Eligibility Criteria
Inclusion
- Eighty ASA Ⅰ - Ⅱ patients aged 3-13 years underwent elective surgery under general anesthesia. No serious cardiovascular disease, no liver and kidney dysfunction, no central nervous system disease and mental disease. Patients undergoing tonsillectomy under general anesthesia were selected as the research objects.
Exclusion
- ASA grade III and above, abnormal heart, lung, liver and kidney function before operation; There were central nervous system diseases and mental diseases, preoperative allergy to anesthetics (dexmedetomidine, esmketamine), family history of malignant high fever, tracheostomy and other artificial airway.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04877639
Start Date
May 1 2021
End Date
May 1 2023
Last Update
August 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital
Wuhan, Hubei, China, 430071